Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF Melanoma

Clinical trial NCT04759846 · WITHDRAWN

Trial details

NCT number: NCT04759846
Sponsor: Pierre Fabre Medicament
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

BRAF V600 Mutation Unresectable Melanoma Metastatic Melanoma Hepatic Impairment

Start date: 2021-01-21
Primary completion: 2023-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.